First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform MILWAUKEE and CAMBRIDGE, Mass.
Currently, the cross-border e-commerce and global trade environment are becoming increasingly complex, and traditional foreign trade models are facing profound challenges. Especially for small and ...